Pfênex, Inc.
(NYSE Amex Equities : PFNX)

( )
PFNX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc. 0.31%64.031.0%$552.83m
AMGNAmgen, Inc. 0.48%224.031.3%$478.38m
BIIBBiogen, Inc. 0.66%283.001.4%$401.87m
ILMNIllumina, Inc. -1.77%313.923.5%$326.48m
VRTXVertex Pharmaceuticals, Inc. 0.06%227.501.9%$276.03m
REGNRegeneron Pharmaceuticals, Inc. -1.70%339.422.6%$247.62m
EXASEXACT Sciences Corp. -1.83%87.9324.0%$226.92m
ALXNAlexion Pharmaceuticals, Inc. 1.26%106.632.0%$179.56m
AAgilent Technologies, Inc. -1.92%86.571.6%$135.93m
INCYIncyte Corp. 2.80%78.202.5%$131.43m
BMRNBioMarin Pharmaceutical, Inc. -1.78%84.624.3%$112.31m
SRPTSarepta Therapeutics, Inc. -0.69%111.6214.6%$108.69m
SGENSeattle Genetics, Inc. -2.77%110.436.1%$106.10m
DERMDermira, Inc. 0.00%18.713.8%$87.37m
BLUEbluebird bio, Inc. -4.74%83.1214.2%$84.78m

Company Profile

Pfênex, Inc. is a clinical-stage biotechnology company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes biosimilars and vaccines. The company was founded on November 19, 2009 and is headquartered in San Diego, CA.